Neobacillus driksii sp. nov. isolated from a Mars 2020 spacecraft assembly facility and genomic potential for lasso peptide production in Neobacillus
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01376-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Asif Hameed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Biotechnology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India. Hauptthemen laut MEDLINE: Phylogeny, RNA, Ribosomal, 16S, Spacecraft, Mars. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NASA | Jet Propulsion Laboratory (JPL), Indian Institute of Technology Madras (IITM).
Abstract (Originalsprache)
During microbial surveillance of the Mars 2020 spacecraft assembly facility, two novel bacterial strains, potentially capable of producing lasso peptides, were identified. Characterization using a polyphasic taxonomic approach, whole-genome sequencing and phylogenomic analyses revealed a close genetic relationship among two strains from Mars 2020 cleanroom floors (179-C4-2-HS, 179-J1A1-HS), one strain from the Agave plant (AT2.8), and another strain from wheat-associated soil (V4I25). All four strains exhibited high 16S rRNA gene sequence similarity (>99.2%) and low average nucleotide identity (ANI) with Neobacillus niacini NBRC 15566 T , delineating new phylogenetic branches within the genus. Detailed molecular analyses, including gyr B (90.2%), ANI (86.4%), average amino acid identity (87.8%) phylogenies, digital DNA–DNA hybridization (32.6%), and percentage of conserved proteins (77.7%) indicated significant divergence from N. niacini NBRC 15566 T . Consequently, these strains have been designated Neobacillus driksii sp. nov., with the type strain 179-C4-2-HS T (DSM 115941 T = NRRL B-65665 T ). N. driksii grew at 4°C to 45°C, pH range of 6.0 to 9.5, and 0.5% to 5% NaCl. The major cellular fatty acids are iso-C 15:0 and anteiso-C 15:0 . The dominant polar lipids include diphosphatidylglycerol, phosphatidylglycerol, phosphatidylethanolamine, and an unidentified aminolipid. Metagenomic analysis within NASA cleanrooms revealed that N. driksii is scarce (17 out of 236 samples). Genes encoding the biosynthesis pathway for lasso peptides were identified in all N. driksii strains and are not commonly found in other Neobacillus species, except in 7 out of 26 recognized species. This study highlights the unique metabolic capabilities of N. driksii , underscoring their potential in antimicrobial research and biotechnology. IMPORTANCE The microbial surveillance of the Mars 2020 assembly cleanroom led to the isolation of novel N. driksii with potential applications in cleanroom environments, such as hospitals, pharmaceuticals, semiconductors, and aeronautical industries. N. driksii genomes were found to possess genes responsible for producing lasso peptides, which are crucial for antimicrobial defense, communication, and enzyme inhibition. Isolation of N. driksii from cleanrooms, Agave plants, and dryland wheat soils, suggested niche-specific ecology and resilience under various environmentally challenging conditions. The discovery of potent antimicrobial agents from novel N. driksii underscores the importance of genome mining and the isolation of rare microorganisms. Bioactive gene clusters potentially producing nicotianamine-like siderophores were found in N. driksii genomes. These siderophores can be used for bioremediation to remove heavy metals from contaminated environments, promote plant growth by aiding iron uptake in agriculture, and treat iron overload conditions in medical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Microbiology and Biotechnology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, India.
- Antimicrobial Resistance and Microbial Ecology Group, School of Medicine, University of Galway, Galway, Ireland.
- Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.
- Center for Integrative Biology and Systems mEdicine (IBSE), Indian Institute of Technology Madras, Chennai, India.
- Wadhwani School of Data Science and AI, Indian Institute of Technology Madras, Chennai, India.
- Centre for One Health, Ryan Institute, University of Galway, Galway, Ireland.
ORCID-Profile: Asif Hameed, Francesca McDonagh, Pratyay Sengupta, Georgios Miliotis, Shobhan Karthick Muthamilselvi Sivabalan, Lukasz Szydlowski, Anna Simpson, Nitin Kumar Singh, Punchappady Devasya Rekha, Karthik Raman, Kasthuri Venkateswaran
Förderung
- NASA | Jet Propulsion Laboratory (JPL)
- Indian Institute of Technology Madras (IITM)
Zitieren
APA
Hameed, A., McDonagh, F., Sengupta, P., Miliotis, G., Sivabalan, S. K. M., Szydlowski, L., Simpson, A., Singh, N. K., Rekha, P. D., Raman, K., & Venkateswaran, K. (2025). Neobacillus driksii sp. nov. isolated from a Mars 2020 spacecraft assembly facility and genomic potential for lasso peptide production in Neobacillus. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01376-24
Vancouver
Hameed A, McDonagh F, Sengupta P, Miliotis G, Sivabalan SKM, Szydlowski L, et al. Neobacillus driksii sp. nov. isolated from a Mars 2020 spacecraft assembly facility and genomic potential for lasso peptide production in Neobacillus. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01376-24
BibTeX
@article{Hameed2025,
author = {Hameed, Asif and McDonagh, Francesca and Sengupta, Pratyay and Miliotis, Georgios and Sivabalan, Shobhan Karthick Muthamilselvi and Szydlowski, Lukasz and Simpson, Anna and Singh, Nitin Kumar and Rekha, Punchappady Devasya and Raman, Karthik and Venkateswaran, Kasthuri},
title = {Neobacillus driksii sp. nov. isolated from a Mars 2020 spacecraft assembly facility and genomic potential for lasso peptide production in Neobacillus},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01376-24}
}
EUVIMED